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A wide variety of contagious and environmental bacteria can cause bovine mastitis worldwide. Antibiotic therapy
is currently used for the treatment of the disease, although its intensive use leads to the emergence of resistant
strains. Bacteriocins arise as potential antibacterial option for mastitis treatment. The aim of this work was to
analyze bacteriocin associated genes as Streptococcus uberis ubericin A (ubaA), ubericin A immunity protein (ubaI),
uberolysin A (ublA), Lantibiotic nisin-U (nsuA and nsuB) in 68 S uberis strains. Furthermore, the ability of the
strains to inhibit important mastitis pathogens was assayed. Results showed that genes were present in combi-
nation and all the strains carried at least one gene. Seven bacteriocion associated gene patterns were identified.
S. uberis strains were able to inhibit different mastitis pathogens and the greatest inhibition was observed in CNS
strains. The results obtained provide new insights on antibacterial activity produced by S. uberis strains against
different mastitis pathogens and could contribute to the development of strategies to treat intramammary
infections.1. Introduction
Bovine mastitis is an infectious disease that affects dairy cows causing
reduction in milk production. A wide variety of contagious and envi-
ronmental bacteria can cause the disease. In order to prevent the disease
different procedures are currently utilized, such as post milking teat
disinfection, adequate maintenance of milking equipment, antibiotic
therapy and culling of chronically infected animals. While the antibiotic
therapy is effective and it has a positive impact on dairy herds, the
intensive use leads to the emergence of resistant bacterial strains
(Sharma et al., 2017). One of the biggest challenges of the dairy industry
is to reduce the use of antibiotics in dairy production searching for
alternative control methods (Py€or€al€a, 2002). Bacteriocins arise as po-
tential antibacterial option for the treatment of mastitis.
Streptococcus uberis is a pathogen recovered from the natural envi-
ronment of dairy cows and produces different types of bacteriocin such as
Lantibiotic nisin U, uberolysin A, Streptococcus uberis ubericin A, ubericin
A immunity protein which have been biochemically and genetically
characterized (Wirawan et al., 2006, 2007; Heng et al., 2007).
Previous studies on bacteriocins against mastitis pathogens have been
carried out by different researchers (Cao et al., 2007; Wu et al., 2007;
Guan et al., 2017). S. uberis is usually found in the dairy cattle environ-
ment where it could be competing with other pathogens (Pieterse andinoso).
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genes of S. uberis isolated from dairy farms have been reported. Thus, the
need for further studies on bacteriocins produced by S. uberis strains with
inhibitory activity against the most prevalent pathogens associated with
bovine mastitis arises. Considering this, the aim of this work was to
analyze bacteriocin associated genes of Streptococcus uberis ubericin A
(ubaA), ubericin A immunity protein (ubaI), uberolysin A (ublA), Lanti-
biotic nisin-U (nsuA and nsuB) in 68 S uberis strains. Furthermore, the
ability of the S. uberis strains to inhibit important mastitis pathogens was
assayed.
2. Materials and methods
2.1. Bacterial isolates
Sixty eight S. uberis and fifteen Gram positive and Gram negative
mastitis pathogens (Staphylococcus aureus (SA-317, SA-318, SA-319, SA-
320), Enterococcus faecalis (EF-218), S. agalactiae (SAG-632),
S. dysgalactiae (SD-633), Escherichia coli (EC-135, EC-136, EC-137, EC-
138)), Coagulase-negative staphylococci (CNS) (CNS-546, CNS-547,
CNS-548) and Corynebacterium spp. (CO-405) were used in this study.
All the isolates were collected from subclinical mastitis cases in different
herds located in the central dairy region of Argentina. All the isolatesgust 2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Mastitis Council methods (National Mastitis Council (NMC), 2004)
without causing stress or harm to the animals.
Milk samples were streaked onto Brain Heart (BH) agar (Laboratorios
Britania S.A., Argentina) subcultured on blood agar (supplemented with
5% sheep blood) and then on Mannitol Salt Agar, Tripticase Soy Agar
(Laboratorios Britania S.A, Argentina) supplemented with 1% Tween 80
and MacConkey Agar (Laboratorios Britania S.A., Argentina). Identifi-
cation was performed according to standardize principles and practices
(Procop and Koneman, 2017). Colony morphology, pigmentation, and
hemolytic characteristics were observed at 48 h. Colonies were subjected
for gram staining and biochemical test for the identification of the iso-
lates. Differentiation between staphylococci and other Gram-positive
cocci was based on catalase test, mannitol fermentation test, coagulase
test. Catalase test was used for the differentiation of Gram positive cocci.
Negative catalase isolates were studied for growth at 45 C and in 6.5%
NaCl, Camp reaction, esculin hydrolysis, sodium hippurate hydrolysis,
arginine hydrolysis, growth in inulin, mannitol, raffinose, salicin, and
sorbitol (Reinoso et al., 2010). From the samples in which growth
occurred in MacConkey Agar, lactose fermenting colonies were selected
for biochemical tests for enterobacteria such as, triple sugar iron, indole
production, lysine decarboxylation, citrate Simmons and urea
production.
S. uberis, E. faecalis, S. agalactiae and S. dysgalactiae strains were
additionally confirmed using molecular techniques as 16S rDNA RFLP
(Jayarao et al., 1992; Khan et al., 2003). Furthermore, S. uberis strains
were previously genotypically characterized by using pulsed-field gel
electrophoresis (PFGE) and PFGE profiles were identified in separate
studies (Reinoso et al., 2015; Moliva et al., 2017).
The handling of animals was conducted according to the guidelines of
the Ethics Committee of Rio Cuarto University (CoEdI). The present study
complies with all regulations.2.2. PCR amplification
DNA extraction was carried out from colonies grown in Triticase Soy
agar (TSA) for 18 h at 37 C. The colonies were resuspended in 1 ml of 1X
TE buffer (10 mM Tris - 5 mM EDTA; pH 7.8), centrifugated and resus-
pended in 1X TE buffer again. Samples were treated with 50 mg/ml of
lysozyme and lysed with 20% w/v of SDS in 50 mM Tris - 20 mM EDTA;
pH 7.8, 20 mg/ml of proteinase K and 10 mg/ml of RNAse. Protein
precipitation was performed with the addition of NaCl 5M. The extracted
supernatant was mixed with chloroform-isoamyl alcohol (49: 1 vol/vol).
DNA was precipitated by the addition of 2.5 volumes of 100% ethanol
and resuspended in buffer TE 1X (10 Mm Tris - 1 mM EDTA; pH 7.5). The
DNAs were stored at –20 C until use.
Bacteriocins associated genes of ubaA, ubaI, ublA, nsuA and nsuBwere
investigated by PCR. Specific oligonucleotide primers were designed for
this study with PRIMER3 software (http://frodo.wi.mit.edu/primer3/)
using each gene sequence deposited in GenBank. All the oligonucleotides
were synthesized by Promega Corporation (Promega, Madison, WI,Table 1
Primers and programs used in the amplification of bacteriocin associated genes.
Target
Gene
Primer Sequence 50-30 Pr
ubaA ATCGGTGGCAAAACTGTAAA GCCCGTTCATGATGGAATTA 93
72
ubaI CTTTGCATGCTCAAGGGAAT CATAGCGGATATTGGAAATCG 94
72
ublA GGGATAGCCTCAGGTACTGC AGCTGAGGCTGAAACTGCTC 93
30
nsuA TGAAGATTTTAATTTGGATCTCATCA TGACAACCACAGGTTGCAGT 94
30
nsuB TCCCCATATGATCTGGCAAT CTGATTATCAACCCGCGAAT 94
30
2
USA). PCR reactions were standardized for the detection of each
virulence-associated gene. Primer sequences, thermocycler programs,
and the corresponding references are summarized in Table 1. The assay
was repeated at least twice. in addition, bacteriocin associated gene
patterns were determined to reveal bacteriocin gene variability in the
fifteen S. uberis strains.2.3. Inhibitory activity
Inhibitory activity by deferred-antagonism method was performed
according to Tagg and Bannister (1979).
Each S. uberis strain culture growth of about 1 cm wide was made
longitudinally in the center of a Todd-Hewitt (TH; Britania, Argentina)
agar plate and incubated in microaerophilia at 37 C for 18 h. Then,
bacteria were inactivated inverting the plate on a filter paper disc
embedded with chloroform during 30min. Paper filter was removed, and
the plates were left in a gas extractor hood for 15 min.
Bacterial suspension of each indicator strain cultured in TH broth was
suspended in sterile distilled water to reach an optical density equivalent
to 3  108 according to the McFarland standard (Baron and Finegold,
1990) and 10 μl streaked perpendicularly to the central culture growth
line of each S. uberis using a calibrated loop. Inhibitory activity was
determined by the lack of growth of the indicator strains around the
inoculum after 18 h of incubation at 37 C. The assay was repeated three
times on different occasions.
Inhibition activity against three or four indicator isolates was cate-
gorized as narrow spectrum and inhibition activity against five or more
indicator isolates was categorized as broad spectrum.2.4. Plasmid extraction
Plasmid extraction was performed according to Anderson and McKay
(1983). Briefly, pelleted cells of S. uberis grown in TSB media were
resuspended in 6.7% sucrose-50 mM Tris-1 mM EDTA, pH 8.0 were lysed
with 50 mg/ml of lysozyme and sodium dodecyl sulfate (20%o [wt/vol]
in 50 mM Tris-20 mM EDTA, pH 8.0). Plasmid DNA alkaline denatural-
ization was carried out with OHNa 2N. Protein precipitation was per-
formed with the addition of NaCl 5M. Supernatant was mixed with
chloroform-isoamyl alcohol (49: 1 vol/vol) and plasmid DNA was
precipitated by the addition of 1 volume of isoamyl alcohol. Plasmids
DNA were resuspended in buffer TE 1X (10 Mm Tris - 1 mM EDTA; pH
7.5) and stored at –20 C until use. Plasmids were visualized by elec-
trophoresis in 0.8% agarose.
3. Results
In the present study, the presence of five bacteriocin associated genes
in 68 S uberis strains was determined by PCR assays. Results revealed that
all strains assayed carried at least one gene. In addition, not all genes
were present in the strains, although combination of bacteriocin associ-




C 3m, (93 C 1m, 50 C 1m, 72 C 1.30 m) x 30,
C 5m
EF203953 115 bp
C 2m, (93 C 1m, 52 C 1m, 72 C 1.30 m) x 30,
C 8 m
EF203953 216 bp
C 3m, (93 C 1.30m, 57 C 30 s, 72 C 1.30 m) x
, 72 C 5 m
DQ650653 129 bp
C 3m, (93 C 1m, 51 C 1.30 m, 72 C 1.30 m) x
, 72 C 8 m
DQ146939 150 bp
C 2m, (93 C 1.20m, 52 C 1m, 72 C 1.30 m) x
, 72 C 5 m
DQ146939 374 bp
Fig. 1. Typical amplicons of S. uberis bacteriocin associated genes. Lane 1: ublA
gene; lane 2: ubaA gene; lane 3: nsuA gene; lane 4: ubaI gene and ubaA gene; lane
5: 100 bp molecular weight marker (Promega) and lane 6: nsuB gene. Please see
Supplementary Fig. 1 for original gel.
M. Lasagno et al. Heliyon 5 (2019) e02393ubaI, ublA, nsuA and nsuB.
ubaI gene was the most common bacteriocin associated gene in the
examined strains (86.76%; 59/68), whereas ubaA gene was found in
52.94% (36/68) of the strains. ublA gene, was found at in the 82.35%
(56/68), indicating that most of the strains harbored this gene. In addi-
tion, nsuA and nsuB genes were harbored by 27.9% (19/68) and 33.82%
(23/68) of the strains, respectively.
Seven bacteriocin associated gene patterns were identified. Pattern I
(ubaIþ, ubaAþ, ublAþ) was the most prevalent in four S. uberis strains
(SU8, SU58, SU200, SU213). Pattern VI, all bacteriocin associated genes
positive, was identified in two strains (SU151, SU210). The remaining 8
strains showed different patterns (Table 2).
Genotypic relationships among 68 S uberis isolates were previously
assayed by PFGE (Reinoso et al., 2015). Macro restriction analysis
revealed thirty-seven PFGE profiles. Among them, eleven strains (SU8,
SU50, SU58, SU90, SU106, SU150, SU151, SU177, SU200, SU210 and
SU213) yielding more than three bacteriocin associated genes were
selected for their action against fifteen mastitis pathogens by
deferred-antagonism method (Table 2). Two strains (SU8 and SU58) hadTable 2
PCR amplification of bacteriocin genes in the selected S. uberis strains.
S. uberis
strains





SU8 þ þ þ - - I A
SU50 þ - þ þ þ II Q
SU58 þ þ þ - - I A
SU90 þ þ þ - þ III O
SU106 - þ þ - þ IV D
SU150 þ þ þ þ - V P
SU151 þ þ þ þ þ VI O
SU177 þ þ - - þ VII F
SU200 þ þ þ - - I N
SU210 þ þ þ þ þ VI C
SU213 þ þ þ - - I K
(þ) Presence; (-) Absence.
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the same bacteriocin pattern and PFGE profile.
In addition, it was found that the eleven S. uberis strains carried
plasmids. All plasmids had a high molecular weight (Fig. 2). PCR assay of
plasmids isolated from each S. uberis strain showed that no plasmid
yielded PCR products of the bacteriocin associated genes.
Results showed that SU200 and SU210 expressed a narrow spectrum
showing inhibition activity against three indicator isolates and yielded
PCR amplicons for three and five bacteriocin associated genes, respec-
tively (Tables 2 and 3). SU213 also showed a narrow spectrum showing
inhibition activity against four isolates and yielded three bacteriocin
associated genes. On the other hand, eight strains (SU8, SU50, SU58,
SU106, SU90, SU151, SU150 and SU177) expressed a broad-spectrum
action inhibition activity against five or more than five indicator
strains tested. SU8, SU50 and SU177 strains showed inhibition activity
against seven and six isolates and yielded PCR products for three and four
bacteriocin associated genes. SU58 showed inhibition activity against
five isolates and yielded PCR products for three bacteriocin associated
genes. SU90 showed inhibition activity against ten of the indicator
strains and yielded four bacteriocin associated genes. SU151 showed
inhibition activity against eleven of the indicator strains and yielded five
bacteriocin associated genes. Whereas SU106 and SU150 strains, showed
inhibitory activity against thirteen indicator isolates and yielded three
and four amplicons of the genes, respectively.
Overall, results showed that CNS were the species that showed
greater susceptibility. In addition, the remaining isolates as S. aureus, E.
coli, E. faecalis and Corynebacterium spp. were also inhibited by different
strains of S. uberis. On the other hand, S. agalactiae SAG-632 and
S. dysgalactiae SD-633 were also assayed, although no inhibition was
observed.
4. Discussion
Bacteriocin associated genes as ubaI, ubaA, ublA, nsuA and nsuB in 68
S uberis strains were examined in this work. Additionally, the ability of
the strains to inhibit important mastitis pathogens was assayed. To our
knowledge this is the first study that investigates the presence of S. uberisFig. 2. Plasmid isolates from S. uberis strains in 0.8 % agarose gel. Lane 1: 1 kb
DNA marker; lanes 2 to 12: SU8, SU50, SU58, SU90, SU106, SU150, SU151,
SU177, SU200, SU210 and SU213 strains. Please see Supplementary Fig. 2 for
original gel.
Table 3
Inhibitory activity of S. uberis strains against mastitis pathogens.
Indicator strains Streptococcus uberis strains
SU8 SU50 SU58 SU90 SU106 SU150 SU151 SU177 SU200 SU210 SU213
E. coli EC-135 þþ þ þ þþ þ þ þ þþ - - þþ
E. coli EC-136 - - - þþ þþ þ þ - - - -
E. coli EC-137 - - - þþ þþþ þþþ þþ þþ - - -
E. coli EC-138 - - - - þþ þþþ - - - - -
S. aureus SA-317 þþþ þþ - þþþ þþ þþþ þ þ - - -
S. aureus SA-318 - - þþ - þ þþ þ - þþ - -
S. aureus SA-319 - - - - þ þ - - þþ - þþ
S. aureus SA-320 - - - þ þþ þþ þ - - - -
CNS-546 þþ þþ þ þþ þþ þþþ þþ þþþ þþ - þþ
CNS-547 þ þþ þþþ þþ þþþ þþ þþ þ - þ -
SCN-548 þþ þþ þþ þþ þþþ þþþ þ þþ - þ -
E. faecalis EF-218 þþ þþ - þþ þþ þþ þþ - - - -
Corynebacterium spp CO-405 þþ - þ þþ þ þ - - þ þþ
S. agalactiae SAG-632 - - - - - - - - - - -
S. dysgalactiae SD-633 - - - - - - - - - - -
-: no zone; þ: zone 10 mm; þþ: zone between <10 mm  20 mm; þþþ: zone >20 mm.
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riocin associated gene patterns.
A high percent of the S. uberis strains assayed yielded ubaI and ublA
genes. The uba locus, which includes ubaA and ubaI genes, was charac-
terized in S. uberis strain E by Heng et al. (2007). These authors reported
that ubaI gene was also present in S. uberis strain O140J, although 0140J
strain lacks ubaA gene. In this work, ubaA was yielded by 34 of the
S. uberis strains assayed. As far as we know there are no screening studies
on uba locus of S. uberis strains. Uberolisin locus, which comprises orf1,
ublA, ublB, ublC, ublD and ublE genes was characterized by Wirawan et al.
(2007) in S. uberis strain 42. These authors reported that ublA could be
amplified by PCR in 18% of 45 S uberis tested (Wirawan et al., 2007),
including S. uberis 0140J. Moreover, results obtained in this study
showed that ublA gene could be amplified in most of the strains indi-
cating that the gene is present in S. uberis strains tested. Nisin U, closely
similar to nisin A from Lactococcus lactis, was described by Wirawan et al.
(2006) in S. uberis strain 42. The locus contains 11 open reading frames.
In this work, nsuA and nsuB genes were harbored by a low percent of the
strains. Similar results were obtained by Wirawan et al. (2006) who re-
ported that 22% of the strains were positive to nsuA gene tested by dot
blot and colony PCR.
Previously, DNA macrorestriction analysis of the 68 S uberis strains
was assessed by PFGE (Reinoso et al., 2015; Moliva et al., 2017). Eleven
S. uberis strains, yielding more than three bacteriocin associated genes,
were selected from thirty-seven PFGE profiles. Plasmid extraction and
antimicrobial activity were carried out with the 11 selected strains. No
bacteriocin associate gene in plasmids could be amplified, suggesting
that bacteriocin genes were localized in the chromosome. These results
are in accordance with those reported in the literature (Heng et al., 2007;
Wirawan et al., 2006, 2007).
Bacteriocins can provide an alternative to antibiotics in the treatment
of intramammary infections due to their antibacterial activity, stability
and low toxicity (Cotter et al., 2013). A study reported the use of nisin for
mastitis (Cao et al., 2007). Nevertheless, this is the first report that
investigated the presence of bacteriocin associated genes produced by
S. uberis strains. Results showed that S. uberis strains yielded bacteriocin
genes in different combinations. In the present study, the S. uberis strains
assayed, showed inhibition against different mastitis pathogens. Ac-
cording to previous reports (Heng et al., 2007; Wirawan et al., 2006)
ubericin A and nisin U showed no inhibition activity against S. aureus,
whereas uberolysin inhibited one of the two S. aureus strains tested
(Wirawan et al., 2007).
Furthermore, the strains assayed in this work were able to inhibit
different mastitis pathogens and the greatest inhibition was observed in
CNS strains. As CNS strains are considered emerging pathogens (De
Visscher et al., 2017), bacteriocins produced by S. uberis could contribute4
to the development of strategies to treat intramammary infections caused
by different pathogens focused on CNS.
In addition, the Gram-negative inhibitory spectrum detected in this
study is important since bacteriocins are more effective against Gram-
positive bacteria. The outer membrane of Gram negative, acts as a bar-
rier against some antimicrobials, detergents and dyes (Gyawali and Ibra-
him, 2014). However, S. uberis strains could inhibit Gram-negative strains.
The results obtained provide new insights on antibacterial activity
produced by S. uberis strains against different mastitis pathogens and
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